Case report · 30 Aug 2023
Conference abstract
Mesenchymal stem/stromal cells (MSCs) in regenerative medicine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recently, stem cells have become more and more popular in regenerative medicine approaches. In a search for a safe and therapeutically beneficial stem cell, many biomedical researchers have turned into using mesenchymal stem/stromal cells (MSCs) in their regenerative medicine endeavors. The pioneering work of Friedenstein in the 1960s with clonal, plastic adherent bone marrow-derived non- hematopoietic cells laid the ground for the introduction of MSCs in the 1990s. Since, MSCs and MSC- like cells have been isolated from various tissue sources and the multipotential differentiation capability has been demonstrated extensively. The minimum criteria for MSCs include plastic adherence, in vitro differentiation into adipogenic, chondrogenic and osteogenic lineages, absence of hematopoietic surface markers, and expression of C105, CD90, and CD73. MSCs have been shown to aid in repair of injured tissues through multiple mechanisms including differentiation, transfer of mitochondria or vesicles, stimulation of endogenous stem cells, suppression of apoptosis, and immunomodulation. Recently, the focus of the MSC therapeutics has sifted from a transdifferentiation approaches into a paracrine effects of MSCs. In particular, immunosuppressive properties of MSCs have attracted much research and great discoveries have been made in identifying therapeutically beneficial molecules secreted by MSCs. MSCs can act on both innate and adaptive immune systems by suppressing T cells, suppressing dendritic cell maturation, reducing B cell activation and proliferation, inhibiting proliferation and cytotoxicity of NK cell, and promoting the generation of regulatory T cells. Hence, MSCs have shown promise in both pre- clinical and clinical trials to treat GVHD and myocardial infarction, and support transplantation. Still, much remains unresolved about basic MSC biology and the mechanisms of MSC therapeutics.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 25 Apr 2019
Extraction of blood mesenchymal stem cells with the low speed centrifugation concept: applications in regenerative medicine
Conference abstract · 12 Sep 2016
External and invasive laser stimulation of intravenously and intra-articulary applied mesenchymal stem cells and PRP in regenerative medicine
Conference abstract
Extraction of blood mesenchymal stem cells with the low speed centrifugation concept: Applications in regenerative medicine
Conference abstract
Amniotic fluid derived mesenchymal stem cells and their potential applications in regenerative medicine
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Article · 2 Jun 2026
Stem Cell Therapy for Diabetes Mellitus: Exploring Cellular Approaches for Pancreatic Regeneration
Article · 2 Jun 2026
Stem Cell Banking and Preservation: Advancing Future Therapeutic Possibilities through Cellular Storage
Article · 2 Jun 2026
Stem Cells in Cardiovascular Regeneration: Emerging Strategies for Heart Repair and Functional Recovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Joni H.Ylostalo”

